Navigation Links
InfoLogix, Inc. to Present at the Growth & Investor Conference in Fort Lauderdale, FL
Date:2/20/2008

HATBORO, Pa., Feb. 20 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, announced today that David Gulian, President and CEO, will present at the Growth & Value Investor Conference to be held at the Westin Fort Lauderdale in Florida on February 27-28, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO )

Mr. Gulian is scheduled to present on Thursday, February 28th followed by a question and answer session. The Growth & Value Investor Conference will be held at the Westin Fort Lauderdale, located at 400 Corporate Drive, Fort Lauderdale, FL. The slide presentation discussed at the conference will be available on InfoLogix's website located at http://www.infologix.com. Electronic versions of the presentation can also be received via email, fax or postal service by contacting InfoLogix's Investor Relations department at the address provided at the end of this release.

InfoLogix's enterprise mobility solutions have been selected by more than 1,400 hospitals and 800 commercial organizations, including 47 of the Fortune 500, to improve productivity, efficiency and revenues. Most recently, InfoLogix has been spotlighted in a FOX Business News feature on medication management and attracted former executives from SAP Americas and GE Healthcare to its team.

About InfoLogix, Inc.

InfoLogix is a leading provider of technology and RFID based intelligence solutions that enable the mobile enterprise. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes for the healthcare industry and the commercial marketplace. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, Adventist Health, Swedish Medical Center, and Stanford School of Medicine. Founded in 2001 and headquartered in suburban Philadelphia, PA, InfoLogix has been named the sixth fastest growing new business in the United States for the last three years by Entrepreneur Magazine. InfoLogix is a publicly-traded company (Nasdaq: IFLG). For more information, visit http://www.infologix.com.

About the Growth & Value Investor Conference

The Growth & Value Investor Conference has carefully designated upwards of 30 outstanding publicly traded companies (NYSE, NASDAQ, AMEX, Canadian listed companies and more) and offers you a live, inside look into the core of their strategies, strength of management and the potential for profit. Each corporate presentation is planned to be followed by a question and answer session and one-on-one meeting opportunities are available. There is nothing to buy at the Growth & Value Investor Conference. All are welcome. Attendance is free.

The Growth & Value Investor Conference, "Spring Break for Wall Street," will be held on Wednesday and Thursday, February 27 & 28, 2008. The Complimentary Cocktail Reception will be held from 4:00 PM - 5:00 PM and the Corporate Presentations will follow from 5:00 PM - 9:00 PM. The Growth & Value Investor Conference is presented by LDV Capital Management, a Registered Investment Advisory Firm Licensed with the State of Florida.


'/>"/>
SOURCE InfoLogix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Meeting through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on ... in 26 people will be diagnosed with epilepsy within their lifetime. With such ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... interoperability, today announced that the company will provide alerting technology to Central ... been recently awarded $1.7 million in federal funds as the sole sub-recipient ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one ... Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the ... techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Officer for the Florida Hospital West Florida Region. McGuinness brings experience in executive ... and engaging staff, physicians and leaders. , In her new role, that officially ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
(Date:12/5/2016)... Research and Markets has announced the addition of the "Global ... and Demand Forecast to 2022" report to their offering. ... , , ... market is expected to grow at a CAGR of 4.5% during ... witnessing high growth, due to growing female geriatric population and increasing ...
(Date:12/5/2016)... England , December 5, 2016 ... Transitions to Deputy Chairman   ... on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative ... has been appointed as non-executive Chairman, effective January 1 st ... of Mission Therapeutics as a non-executive Director in July 2015. ...
Breaking Medicine Technology: